title: Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line.
abstract: GH3 cells are a clonal strain from a rat pituitary tumor that synthesizes and secretes both PRL and GH. The peculiarity of these cells is that they do not express receptors for dopamine; thus the hormone release is insensitive to the inhibitory effect of dopamine and D2 receptor agonists. Exposure of GH3 cells to epidermal growth factor for 4 consecutive days markedly altered the cell morphology, from a spherical appearance to an elongated flattened shape, and increased the cell size. These morphological changes were accompanied by the functional expression of D2 dopamine receptors as shown by the presence of a specific, saturable, and stereoselective high affinity binding for [3H]spiroperidol in epidermal growth factor-treated cells and by the fact that the selective D2 agonist quinpirole recovered the property to inhibit PRL secretion in the cell cultures exposed to the neurotrophic factor. The effect of EGF on the functional expression of D2 receptors was dose dependent (EC50 = 8 pM) and reversible. These data suggest that EGF elicits major effects on the expression of specific genes leading to the differentiation of GH3 cells into lactotroph-like cells endowed with dopamine D2 receptors.
authors.affiliation: Institute of Pharmacology and Experimental Therapeutics, School of Medicine, University of Brescia, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Missale
authors.forename: L
authors.initials: L
authors.lastname: Castelletti
authors.forename: F
authors.initials: F
authors.lastname: Boroni
authors.forename: M
authors.initials: M
authors.lastname: Memo
authors.forename: P
authors.initials: P
authors.lastname: Spano
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D002478:Cells, Cultured; D015259:Dopamine Agents / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology; D007700:Kinetics; D010903:Pituitary Gland, Anterior / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010911:Pituitary Neoplasms; D011188:Potassium / Q000494:pharmacology; D011388:Prolactin / Q000378:metabolism; D019257:Quinpirole; D051381:Rats; D011954:Receptors, Dopamine / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism*; D017448:Receptors, Dopamine D2; D013134:Spiperone / Q000378:metabolism
chemical_list: D015259:Dopamine Agents; D004873:Ergolines; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D019257:Quinpirole; D013134:Spiperone; D004815:Epidermal Growth Factor; D011388:Prolactin; D011188:Potassium